Actively Recruiting
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Led by AstraZeneca · Updated on 2026-02-24
600
Participants Needed
19
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multicentre observational study on treatment approaches and HER2 positive status prevalence in different stages of bladder cancer and PD-L1-positive status in metastatic bladder cancer in Russian Federation
CONDITIONS
Official Title
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Signed informed consent form including consent for FFPE tumor tissue sample testing
- Confirmed diagnosis of urothelial bladder cancer at NMIBC, MIBC, or mBC stage at study entry
- For NMIBC patients: TURBT performed between 1 and 12 months before study entry
- NMIBC patients must have at least one high-risk feature: T1 tumor, High grade/G3 tumor, carcinoma in situ, or multiple, recurrent, and large tumors (diameter 63 3 cm)
- For MIBC patients: cystectomy performed between 2 and 12 months before study entry
- For mBC patients: metastatic bladder cancer diagnosed within 12 months before study entry
- Availability of medical history data
- Availability of FFPE tumor tissue sample obtained during biopsy and/or surgery
You will not qualify if you...
- Participation in any interventional trial since urothelial bladder cancer diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 19 locations
1
Research Site
Arkhangelsk, Russia
Actively Recruiting
2
Research Site
Barnaul, Russia
Actively Recruiting
3
Research Site
Chelyabinsk, Russia
Actively Recruiting
4
Research Site
Krasnodar, Russia
Not Yet Recruiting
5
Research Site
Krasnoyarsk, Russia
Actively Recruiting
6
Research Site
Makhachkala, Russia
Not Yet Recruiting
7
Research Site
Moscow, Russia
Not Yet Recruiting
8
Research Site
Moscow, Russia
Actively Recruiting
9
Research Site
Nizhny Novgorod, Russia
Not Yet Recruiting
10
Research Site
Novosibirsk, Russia
Not Yet Recruiting
11
Research Site
Obninsk, Russia
Not Yet Recruiting
12
Research Site
Omsk, Russia
Actively Recruiting
13
Research Site
Saint Petersburg, Russia
Actively Recruiting
14
Research Site
Saint Petersburg, Russia
Not Yet Recruiting
15
Research Site
Tomsk, Russia
Not Yet Recruiting
16
Research Site
Tyumen, Russia
Actively Recruiting
17
Research Site
Ufa, Russia
Actively Recruiting
18
Research Site
Ufa, Russia
Not Yet Recruiting
19
Research Site
Yekaterinburg, Russia
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here